Genetic events and the role of TGFβ in epithelial tumour progression
- 1 January 1999
- journal article
- review article
- Published by Wiley in The Journal of Pathology
- Vol. 187 (1) , 82-90
- https://doi.org/10.1002/(sici)1096-9896(199901)187:1<82::aid-path248>3.0.co;2-8
Abstract
The mouse skin model of chemical carcinogenesis has been very well characterized with respect to epigenetic changes, which occur during tumour cell initiation, promotion and progression. The use of transgenic and gene knock-out mice has contributed greatly to knowledge in this area. The H-ras genetic locus has been shown to undergo multiple genetic changes, including mutagenic activation, amplification of the mutant gene, and loss of the normal allele. These different genetic events lead to thresholds of ras activity which contribute to different stages along the pathway to neoplasia. The genetic and epigenetic events which lead to tumour invasion and metastasis have been less well characterized than studies on tumour initiation and promotion, despite the fact that it is metastases which ultimately kill the animal/patient. In the mouse skin model, loss of p53 contributes to malignant conversion. Gene deletion of the INK4 locus is associated with transformation to a highly invasive spindle cell tumor phenotype. This spindle cell transformation can also be induced in vitro or in vivo by TGF beta 1, possible by synergizing with mutant H-ras. TGF beta can have both positive and negative effects on tumourigenesis, acting early as a tumour suppresser, but later as a stimulator of tumour invasion. It is this latter effect which may be clinically more significant, since many human tumours overexpress TGF beta, yet the majority still retain the intracellular signaling systems necessary for the cell to respond to this growth factor.Keywords
This publication has 113 references indexed in Scilit:
- Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma developmentOncogene, 1998
- Molecular cloning of human TAK1 and its mutational analysis in human lung cancerInternational Journal of Cancer, 1998
- Mutations of the Transforming Growth Factor-β Type II Receptor Gene and Genomic Instability in Hereditary Nonpolyposis Colorectal CancerBiochemical and Biophysical Research Communications, 1995
- Effects of TGF‐β1 (transforming growth factor‐β1) on the cell cycle regulation of human breast adenocarcinoma (MCF‐7) cellsFEBS Letters, 1995
- Location of stem cells of human hair follicles by clonal analysisCell, 1994
- Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v‐Ha‐ras oncogeneMolecular Carcinogenesis, 1993
- Comparison of ras activation during epidermal carcinogenesis in vitro and in vivoCarcinogenesis: Integrative Cancer Research, 1991
- TGF‐β1 and skin carcinogenesis: Antiproliferative effect in vitro and TGF‐β1 mRNA expression during epidermal hyperproliferation and multistage tumorigenesisMolecular Carcinogenesis, 1991
- Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7Cell, 1990
- An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissueNature, 1986